# Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs

> **NCT01436929** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Silymarin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01436929
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436929, "Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01436929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*